Investing.com - AstraZeneca (NASDAQ:AZN) reported on Friday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
AstraZeneca announced earnings per share of $1.72 on revenue of $10.77B. Analysts polled by Investing.com anticipated EPS of $1.58 on revenue of $10.51B.
AstraZeneca shares are down 32.95% from the beginning of the year, still down 3.95% from its 52 week high of $11,289.60 set on July 18. They are under-performing the STOXX 600 which is down 10.15% from the start of the year.
AstraZeneca follows other major Healthcare sector earnings this month
AstraZeneca's report follows an earnings beat by GSK plc on Wednesday, who reported EPS of $0.347 on revenue of $6.93B, compared to forecasts EPS of $0.2642 on revenue of $7.22B.
Renalytix AI had missed expectations on June 30 with fourth quarter EPS of $-0.2 on revenue of $812K, compared to forecast for EPS of $-0.0863 on revenue of $2.02M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar